4th Apr 2007 13:13
Henderson Morley PLC04 April 2007 FOR IMMEDIATE RELEASE 04 APRIL 2007 HENDERSON MORLEY PLC (AIM) Business: Drug Discovery DIRECTORS' OPTIONS The Board of Henderson Morley plc, the AIM listed drug discovery company, announces today that it has granted options over 2,500,000 Ordinary Shares at an exercise price of 2.25p to Chairman Andrew Knight, options over 2,500,000 Ordinary Shares at an exercise price of 2.25p to Chief Executive Dr Ian Pardoe and options over 800,000 Ordinary Shares at an exercise price of 2.25p to Finance Director Christopher Pate. These options are exercisable for a period of five years from 1 May 2007. --ENDS-- Enquiries: HENDERSON MORLEY PLC Tel: 0121 442 4600Andrew Knight, Chairman BISHOPSGATE COMMUNICATIONS LTD Tel: 020 7562 3350Maxine BarnesNick Rome BREWIN DOLPHIN SECURITIES LTD Tel: 0113 241 0126Neil Baldwin Further information on Henderson Morley plc can be accessed through theCompany's website at www.henderson-morley.com This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
HML.L